GnRH analogues in the treatment of uterine fibroids

Human Reproduction

Volumn 11, Issue SUPPL. 3, 1996, Pages 33-41

  Golan, A ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Fibroids; GnRH analogues; Treatment; Uterine tumours

Indexed keywords

GONADORELIN DERIVATIVE;

ADULT; CONFERENCE PAPER; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; SIDE EFFECT; UTERUS MYOMA; UTERUS SURGERY;

EID: 0030317403     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/11.suppl_3.33     Document Type: Conference Paper

References (31)

1. Balash, J., Manau, B., Mino, J. et al. (1995) Sequential gonadotropin-releasing hormone agonist/ low dose oral contraceptive treatment for leiomyomata uteri. Hum. Reprod., 10, 529-532.
2. Benagiano, G., Priiero, F.M. and Villani, C. (1993) GnRH analogues in the management of uterine leiomyomas and other benign gynecological situations. In Lunenfeld, B. and Insler, V. (eds), GnRH Analogues. The State of Art 1993. Parthenon Publishing, Carnforth. UK, pp 55-85.
3. Blumenfeld, Z., Thaler, I., Weiner, Z. et al. (1991) Treatment of uterine leiomyomata with GnRH analog (nafarelin): a clinical protocol of interrupted (on-and-off) treatment. In Blumenfeld, Z. (ed.), Advances in the Study of GnRH Analogs. Proceedings of the 2nd International Symposium on GnRH Analogs. Vol. 4. Parthenon Publishing Group Ltd, London, pp. 123-131.
4. Broekmans, F.J., Hompes, P.G. and Schoemaker, J. (1993) GnRH agonist of uterine leioma: complete followed by partial pituitary suppression (preliminary results). [Abstr.] Gynecol. Endocrinol. 7, 37.
5. Cirkel, U., Ochs, H., Roehl, A. and Schneider, H.P. (1994) Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone analog depot therapy. Acta Obstet. Gynecol. Scand., 73, 328-332.
6. Colgan, T.J., Pendergast, S. and LeBlanc, M. (1993) The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogs. Hum. Pathol., 24, 1073-1077.
7. Coutinho, E.M., Boulanger, G.A. and Goncalve, M.T. (1986) Regression of uterine leiomyomas after treatment with gestrinone, an anti-estrogen, antiprogesterone. Am. J. Obstet. Gynecol., 155, 761.
8. Donnez, J., Gillerot, S., Bourgonjon, D. et al. (1990) Neodymium: YAG laser hysteroscopy in large submucous fibroids. Fertil. Steril., 54, 999-1003.
9. Filicori, M.D., Hall, D.A., Loughlin, J.S. et al. (1983) A conservative approach of the management of uterine leiomyomata: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am. J. Obstet. Gynecol., 147, 726-727.
10. Friedman, A.J., Barbieri, R.L., Benacerraf, B.R. and Schiff, I. (1987) Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Fertil. Steril., 48, 560-564.
11. Friedman, A.J., Harrison Atlas, D., Barbieri, R.L.et al. (1989) A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyoma. Fertil. Steril., 51, 251-256.
12. Friedman, A.J., Lobel, S.M., Rein, M.S. and Barbieri, R.L. (1990) Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am. J. Obstet. Gynecol., 163, 1114-1119.
13. Friedman, A.J., Daly, M., Juneau-Norcross, M. et al. (1993) A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin 'add-back' regimens for women with leiomyomata uteri. J. Clin. Endocrinol. Metabol., 76, 1439-1445.
14. Golan, A., Bukovsky, I., Schneider, D. et al. (1989) D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leimyomas. Fertil. Steril., 52, 406-411.
15. Golan, A., Bukovsky, I., Pansky, M. et al. (1993) Preoperative gonadotropin-releasing hormone agonist treatment in surgery for uterine leiomyomata. Hum. Reprod., 8, 450-452.
16. Johannissen, E. and Brosens, I. (1993) The effect of Decdapeptyl on the growth of leiomyomata. [Abstr.] Gynecol. Endocrinol., 7, 36.
17. Kettel, L.M., Murphy, A.A., Morales A.J. et al. (1993) Rapid regression of uterine leiomyomas is response to daily administration of gonadotropin-releasing hormone antagonists. Fertil. Steril., 60, 642-646.
18. Lumsden, M.D., West, C.P., Baird, D.T. (1987) Goserelin therapy before surgery for uterine fibroids. Lancet, i, 36-37.
19. Lumsden, M.A., West, C.P., Bramley, T. et al. (1988) The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonist. Br. J. Obstet. Gynaecol., 95, 1299-1304.
20. Maheux, R. Samson, Y., Farid, N.R. et al. (1987) Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis. Fertil. Steril., 48, 315-317.
21. Matta, W.H., Stabile, I., Shaw, R.W., and Campbell, S. (1988) Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil. Steril., 49, 1083-1088.
22. Mettler, L. and Semm, K. (1993) Laparoscopic approach of fibroid excision after treatment with GnRH analogue. [Abstr. no. 39] Gynecol. Endocrinol., 7, 30.
23. Perino, A., Chianchiano, N., Petronio, M. and Cittadini, E. (1993) Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study. Fertil. Steril., 59, 507-510.
24. Rein, M.S., Friedman, A.J., Stuart, J.M. and MacLaughlin, D.T. (1990) Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil. Steril., 53, 1018-1023.
25. Upadhyaya, N.B., Doody, M.C. and Googe, P.B. (1990) Histopathological changes in leiomyomata treated with leuprolide acetate. Fertil. Steril., 54, 811-814.
26. Van Leusden, H.A. (1986) Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp-LHRH. Lancet, ii, 1213.
27. Vollenhoven, B.J., Pearce, P., Herington, A.C. et al. (1994) Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotropin-releasing hormone agonist pretreated women. Clin. Endocrinol. Oxf., 40, 537-544.
28. Watanabe, Y., Nakamura, G., Matsuguchi, H. et al. (1992) Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leimyomata in Japanese women. Fertil. Steril., 58, 66-71.
29. West, C.P., Lumsden, M.A., Lawson, S. et al. (1987) Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil. Steril., 48, 45-51.
30. West, C.P., Lumsden, M.A. and Baird, D.T. (1992) Goserelin (Zoladex) in the treatment of fibroids. Br. J. Obstet. Gynecol., 99, 27-30.
31. Ylikovkala, O., Tiitinen, A., Hulkko, S. et al. (1995) Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study. Hum. Reprod., 10, 1470-1474.